CHIRON CAPITAL MANAGEMENT, LLC recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
3421 BANNERMAN RD TALLAHASSEE, FL 32312
As of the latest 13F report, the guru’s equity portfolio contained 127 stocks valued at a total of $159.00Mil. The top holdings were BMY(26.09%), XBI(7.82%), and FDN(4.28%).
According to GuruFocus data, these were CHIRON CAPITAL MANAGEMENT, LLC’s top five trades of the quarter.
Bristol-Myers Squibb Co
CHIRON CAPITAL MANAGEMENT, LLC reduced their investment in NYSE:BMY by 80,823 shares. The trade had a 3.72% impact on the equity portfolio. During the quarter, the stock traded for an average price of $76.11.
On 07/25/2022, Bristol-Myers Squibb Co traded for a price of $72.84 per share and a market cap of $155.08Bil. The stock has returned 9.67% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Bristol-Myers Squibb Co has a price-earnings ratio of 25.82, a price-book ratio of 4.90, a price-earnings-to-growth (PEG) ratio of 3.23, a EV-to-Ebitda ratio of 9.69 and a price-sales ratio of 3.44.
The price-to-GF Value ratio is 0.98, earning the stock a GF Value rank of 5.
First Trust Dow Jones Internet Index Fund
During the quarter, CHIRON CAPITAL MANAGEMENT, LLC bought 44,838 shares of ARCA:FDN for a total holding of 53,396. The trade had a 3.59% impact on the equity portfolio. During the quarter, the stock traded for an average price of $150.04.
On 07/25/2022, First Trust Dow Jones Internet Index Fund traded for a price of $136.02 per share and a market cap of $4.28Bil. The stock has returned -45.89% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, First Trust Dow Jones Internet Index Fund has a price-earnings ratio of 25.38 and a price-book ratio of 4.36.
Technology Select Sector SPDR ETF
The guru established a new position worth 41,625 shares in ARCA:XLK, giving the stock a 3.34% weight in the equity portfolio. Shares traded for an average price of $139.3 during the quarter.
On 07/25/2022, Technology Select Sector SPDR ETF traded for a price of $136.35 per share and a market cap of $40.49Bil. The stock has returned -11.05% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Technology Select Sector SPDR ETF has a price-earnings ratio of 22.86 and a price-book ratio of 7.42.
Boeing Co
During the quarter, CHIRON CAPITAL MANAGEMENT, LLC bought 14,920 shares of NYSE:BA for a total holding of 19,490. The trade had a 1.29% impact on the equity portfolio. During the quarter, the stock traded for an average price of $148.21.
On 07/25/2022, Boeing Co traded for a price of $156.64 per share and a market cap of $92.67Bil. The stock has returned -29.29% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Boeing Co has a EV-to-Ebitda ratio of -102.14 and a price-sales ratio of 1.51.
The price-to-GF Value ratio is 0.68, earning the stock a GF Value rank of 10.
Pfizer Inc
CHIRON CAPITAL MANAGEMENT, LLC reduced their investment in NYSE:PFE by 24,022 shares. The trade had a 0.79% impact on the equity portfolio. During the quarter, the stock traded for an average price of $50.97.
On 07/25/2022, Pfizer Inc traded for a price of $51.77 per share and a market cap of $290.48Bil. The stock has returned 28.00% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Pfizer Inc has a price-earnings ratio of 11.88, a price-book ratio of 3.51, a price-earnings-to-growth (PEG) ratio of 1.13, a EV-to-Ebitda ratio of 8.82 and a price-sales ratio of 3.22.
The price-to-GF Value ratio is 0.61, earning the stock a GF Value rank of 8.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
